SCHEMBL19639554

SCHEMBL19639554

CC(C)ONC(=N)N(OC(=O)C(C)O)c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
GAA P10253 2/20 0.32
KDM4E B2RXH2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
TSHR P16473 1/20 0.32
PDCD1 Q15116 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 2/20 0.31
LMNA P02545 2/20 0.31
HTT P42858 2/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.30
ADRB2 P07550 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19639565 0.92 CHRNB2 (0.32) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL19639581 0.87 SMN1; SMN2 (0.37) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL19639574 0.86 SMN1; SMN2 (0.33) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL19639548 0.84 HCAR2 (0.35) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL19639531 0.84 ALDH1A1 (0.42) SMN1; SMN2KDM4ETDP1TSHRPDCD1
SCHEMBL19639578 0.84 HCAR2 (0.35) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2
SCHEMBL19639525 0.77 KDM4E (0.35) SMN1; SMN2GAAKDM4ETDP1KMT2A
SCHEMBL19639560 0.77 ESR1 (0.35) SMN1; SMN2GAAKDM4ETDP1ALDH1A1
SCHEMBL19639549 0.72 ESR1 (0.32) SMN1; SMN2KMT2AALDH1A1LMNATP53
Lactic Acid SCHEMBL19639552 0.69 TSHR (0.35) CHRNB2CHRNB4CHRNA3CHRNA4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170342026-A1 ISOPROPOXY-PHENYLGUANIDINE SERIES SALT AND APPLICATION THEREOF IN PREPARING GROWTH PROMOTERS FOR ANIMAL FEED Guangzhou Insighter Biotechnology Co., Ltd. (CN) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342026-A1 ISOPROPOXY-PHENYLGUANIDINE SERIES SALT AND APPLICATION THEREOF IN PREPARING GROWTH PROMOTERS FOR ANIMAL FEED SUCNR1, SORD, BPGM CHRNB2 4239/4885CHRNB4 4528/4885CHRNA3 4407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.